Trial Site Detail

 

Drug:
IPI-493
Trial:
A Phase I Dose Escation Study of IPI-493
Conditions: Solid Tumors
Trial Status:
Terminated

 

University of Colorado

1665 N. Ursula St.     
Aurora , CO 80045
USA

 

Principal Investigator:
Colin Weekes, MD, PhD
Contact:
Stacy Grolnic, RN 720-848-0655 stacy.grolnic@uchsc.edu
Activation Status of this Site:
Active
Notes about this Site:
University of Colorado Website:
http://www.uch.edu/conditions/cancer/index1.aspx

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.